*Retractable Technologies, Inc. (RVP)
Retractable Technologies (RVP) manufactures safety medical products. RVP develops retractable needles and syringes, glass syringes and Luer caps. Its injection devices consist of VanishPoint® syringes,which are the gold standard for retractable needle syringes and virtually eliminate exposure to the contaminated needle, reducing the risk of needlestick injury. While U.S. sales have been flat for syringes, international sales have risen consistently. Blood collection and infusion devices sales have almost tripled in three years and do not require additional components such as sheaths, metal clips or activation buttons. Retractable Technologies’ trailing twelve-month net income of $1.1 million is the highest level since 2015.
Operating income in the third quarter of 2019 increased to $978,000 compared to a loss of $60,000 in the prior year period. The company has been gradually eliminating long-term debt. There are multiple catalysts resulting in relative strength for this growth stock. The syringe market is growing at a CAGR of 9%. Retractable Technologies has a competitive advantage and a strong financial foundation.The company’s newer product lines are gaining traction in a market with high barriers to entry, and international sales have helped to improve margins. With growth expected to continue and institutions and insiders accumulating shares, we’re optimistic about RVP’s outlook.
Faris Sleem, The Bowser Report, www.thebowserreport.com, 757-877-5979, January 2020